Updated Jul 16, 2026
Honore Tage has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $241K.
Honore Tage is associated with Vanda Pharmaceuticals Inc., as indicated by recent SEC filings. However, there is limited publicly available information regarding his background and achievements, suggesting he may not be a widely recognized figure in the industry.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-08 | VNDA | Vanda Pharmaceuticals Inc. | A — Grant or award | 41.6K | $0.00 | |
| 2026-02-24 | VNDA | Vanda Pharmaceuticals Inc. | S — Open-market sale | 30.0K | $8.03 | $241K |
Honore Tage is associated with Vanda Pharmaceuticals Inc., as indicated by recent SEC filings. However, there is limited publicly available information regarding his background and achievements, suggesting he may not be a widely recognized figure in the industry.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($241K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Honore Tage profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.